Skip to main content
Contact Us
Subscribe
e-Edition
Sign up for free daily newsletters
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Home
Contact Us
Terms of Use
Privacy Policy
Subscription Services
Submission Forms
Promote Your Event
e-Edition
Place an Ad
Local Weather
News
Local News
Elections
Sports
Business
Events
Obits
Legals
Photos
Videos
e-Edition
Recent e-Editions
Archived e-Editions (Press Reader)
Classifieds
Place an ad
Submit News
Letter to the Editor
Anniversaries
Engagement
Birth Announcement
Wedding
News Tips
Other KPC Newspapers
Herald Republican (Steuben County)
News Sun (Noble and LaGrange counties)
The Star (DeKalb County)
Advance Leader (western Noble County)
Albion New Era (central Noble County)
Butler Bulletin (Butler, DeKalb County)
Garrett Clipper (Garrett, DeKalb County)
Churubusco News (Churubusco and Whitley County)
Greater Fort Wayne Business Weekly
IN|Aboite News
IN|All Sports
IN|Fort Wayne
IN|New Haven News
IN|Northwest News (Huntertown, northwest Allen County)
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by AlloVir
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients
April 20, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Appoints Shawn Tomasello to Its Board of Directors
March 31, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Initiates Global Phase 3 Registrational Study of Posoleucel for Prevention of Life-Threatening Viral Infections from Six Common Viruses in High-Risk, Allogeneic Hematopoietic Cell Transplant Patients
March 22, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
February 11, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook
February 10, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVir’s Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults and Children Post-Allogeneic Stem Cell Transplantation
January 05, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 03, 2022
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Announces Departure of Chief Medical Officer Augustin Melian
December 16, 2021
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Announces Positive Preliminary Data from the Ongoing Phase 2 Posoleucel Multi-Virus Prevention Study at the 63rd American Society of Hematology Annual Meeting
December 11, 2021
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir to Host Virtual Investor Event
December 02, 2021
From
AlloVir
Via
Business Wire
AlloVir Reports Third Quarter 2021 Financial Results
November 05, 2021
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Reports Second Quarter 2021 Financial Results
August 06, 2021
From
AlloVir
Via
Business Wire
Tickers
ALVR
AlloVir Reports First Quarter 2021 Financial Results
May 06, 2021
From
AlloVir
Via
Business Wire
Tickers
ALVR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.